Axillary lymph node dissection for intraductal breast carcinoma-is it indicated?
Open Access
- 15 May 1987
- Vol. 59 (10), 1819-1824
- https://doi.org/10.1002/1097-0142(19870515)59:10<1819::aid-cncr2820591023>3.0.co;2-v
Abstract
One hundred patients with intraductal breast carcinoma (DCIS) were treated with either mastectomy (49 patients) or radiation therapy (51 patients). All patients underwent axillary lymph node dissection (average number of nodes removed, 16) as part of their treatment. No patient had any positive axillary lymph nodes. There has been one recurrence in each treatment group (median follow‐up, 27 months) and no deaths. Intraductal breast carcinoma has little potential for metastasis to axillary lymph nodes.This publication has 19 references indexed in Scilit:
- Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapyCancer, 1986
- Needle Localization of Nonpalpable Breast MassesArchives of Surgery, 1985
- Staging and treatment of clinically occult breast cancerCancer, 1984
- Analysis of the Prognosis of Minimal and Occult Breast CancersArchives of Surgery, 1983
- Intraductal carcinoma of the breast: Follow-up after biopsy onlyCancer, 1982
- Axillary lymph node metastases in patients with occult noninvasive breast carcinomaCancer, 1980
- Noninvasive Breast CarcinomaAnnals of Surgery, 1980
- Intraductal CarcinomaPublished by American Medical Association (AMA) ,1978
- Intraductal carcinoma of the breast (1960–1969)Cancer, 1971
- Epithelial-stromal junction of intraductal carcinoma of the breastCancer, 1970